Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan How

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|March 9, 2012
ENMD-2076 for hematological malignanciesJonathan How, Karen Yee
IEEE Transactions on Pattern Analysis and Machine Intelligence|July 12, 2018
Dynamic Clustering Algorithms via Small-Variance Analysis of Markov Chain Mixture ModelsTrevor Campbell, Brian Kulis, Jonathan How
Journal of Neurochemistry|January 27, 2007
Beta-amyloid increases somatostatin expression in cultured cortical neuronsCatherine Geci, Jonathan How, Haydar Alturaihi, et al.
American Journal of Clinical Pathology|January 18, 2014
Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literatureMoussab Damlaj, Ramila Amre, Phil Wong, et al.
Cancer|June 28, 2012
Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemiaJonathan How, Jenna Sykes, Vikas Gupta, et al.
Plos One|January 16, 2013
Comprehensive analysis and identification of the human STIM1 domains for structural and functional studiesJonathan How, Ai Zhang, Margaret Phillips, et al.
Hematological Oncology|March 18, 2026
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)Francesco Passamonti, James M Foran, Anand Tandra, et al.
Leukemia & Lymphoma|February 17, 2015
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemiaJonathan How, Mark D Minden, Leber Brian, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|March 9, 2012
ENMD-2076 for hematological malignanciesJonathan How, Karen Yee
IEEE Transactions on Pattern Analysis and Machine Intelligence|July 12, 2018
Dynamic Clustering Algorithms via Small-Variance Analysis of Markov Chain Mixture ModelsTrevor Campbell, Brian Kulis, Jonathan How
Journal of Neurochemistry|January 27, 2007
Beta-amyloid increases somatostatin expression in cultured cortical neuronsCatherine Geci, Jonathan How, Haydar Alturaihi, et al.
American Journal of Clinical Pathology|January 18, 2014
Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literatureMoussab Damlaj, Ramila Amre, Phil Wong, et al.
Cancer|June 28, 2012
Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemiaJonathan How, Jenna Sykes, Vikas Gupta, et al.
Plos One|January 16, 2013
Comprehensive analysis and identification of the human STIM1 domains for structural and functional studiesJonathan How, Ai Zhang, Margaret Phillips, et al.
Hematological Oncology|March 18, 2026
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)Francesco Passamonti, James M Foran, Anand Tandra, et al.
Leukemia & Lymphoma|February 17, 2015
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemiaJonathan How, Mark D Minden, Leber Brian, et al.
Pageof 1